Drug Shortage Report for REVATIO
Report ID | 128257 |
Drug Identification Number | 02341611 |
Brand name | REVATIO |
Common or Proper name | Revatio IV |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SILDENAFIL |
Strength(s) | 0.8MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | Vial 12.5ml |
ATC code | C02KX |
ATC description | OTHER ANTIHYPERTENSIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-11-11 |
Estimated end date | |
Actual end date | 2021-01-20 |
Shortage status | Resolved |
Updated date | 2021-01-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2021-01-21 | English | Compare |
v9 | 2021-01-20 | French | Compare |
v8 | 2021-01-20 | English | Compare |
v7 | 2021-01-18 | French | Compare |
v6 | 2021-01-18 | English | Compare |
v5 | 2021-01-11 | French | Compare |
v4 | 2021-01-11 | English | Compare |
v3 | 2020-11-12 | English | Compare |
v2 | 2020-11-11 | French | Compare |
v1 | 2020-11-11 | English | Compare |
Showing 1 to 10 of 10